azacitidine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
azacitidine
Jun 19, 2024, 07:28 |
Insight
Naval Daver presents findings of the ENHANCE-3 study at EHA2024 - AML Hub
AML Hub shared the following post on X: . "CONGRESS EHA2024 | Naval Daver…
Jun 18, 2024, 14:51 |
Insight
Amer Zeidan: Our newest paper on 61 TP53-mutated AML
Amer Zeidan shared on X: "Our newest paper with a detailed Integrated analysis of genetic,…
Jun 2, 2024, 22:16 |
Insight
ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Clinical trial results suggest new treatment options could reduce need for stem cell transplants and…
Apr 5, 2024, 08:22 |
Insight
Hagop Kantarjian: Low-dose azacitidine plus venetoclax - in patients with AML unable to complete standard consolidation strategies
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Jan 5, 2024, 17:36 |
Insight
Talha Badar: What is the right duration of Venetoclax with HMA for AML?
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, shared on X/Twitter:…
Jul 7, 2023, 09:51 |
Opinion
How I do venetoclax+azacitidine induction AML - Aaron Goodman
How I do venetoclax+azacitidine induction AML Ven 400 mg* days 1-28+aza 75mg/m2 days 1-7 BMBx…
All:
6
Posts:
1 - 100
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube